P&K Skin Research Center Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	17,671	14,843	17,957
Revenue Growth (YoY)	12.08%	-17.34%	-
Cost of Revenue	9,085	7,668	6,865
Gross Profit	8,586	7,175	11,092
Selling, General & Admin	3,787	3,918	3,428
Research & Development	1,512	1,357	1,670
Other Operating Expenses	22.57	29.3	19.82
Operating Expenses	5,797	5,796	5,452
Operating Income	2,788	1,379	5,640
Interest Expense	-27.65	-32.77	-25.77
Interest & Investment Income	3,998	3,808	2,215
Currency Exchange Gain (Loss)	-0.01	-0.29	0.03
Other Non Operating Income (Expenses)	-97.14	63.36	546.89
EBT Excluding Unusual Items	6,662	5,217	8,377
Gain (Loss) on Sale of Investments	1,269	140.01	-185.18
Gain (Loss) on Sale of Assets	-0.31	-0	-0.97
Pretax Income	7,931	5,357	8,190
Income Tax Expense	1,291	656.54	1,060
Earnings From Continuing Operations	6,640	4,700	7,130
Minority Interest in Earnings	123.07	112.75	-
Net Income	6,763	4,813	7,130
Net Income to Common	6,763	4,813	7,130
Net Income Growth	27.06%	-32.50%	-
Shares Outstanding (Basic)	29	30	30
Shares Outstanding (Diluted)	29	30	30
Shares Change (YoY)	-2.26%	0.58%	-
EPS (Basic)	230.84	160.48	239.12
EPS (Diluted)	230.84	160.48	239.12
EPS Growth	30.00%	-32.89%	-
Free Cash Flow	8,335	4,023	6,277
Free Cash Flow Per Share	284.49	134.13	210.50
Dividend Per Share	30.000	30.000	35.000
Dividend Growth	-14.29%	-14.29%	-
Gross Margin	48.59%	48.34%	61.77%
Operating Margin	15.78%	9.29%	31.41%
Profit Margin	38.27%	32.43%	39.71%
Free Cash Flow Margin	47.17%	27.10%	34.95%
EBITDA	4,624	3,114	7,108
EBITDA Margin	26.17%	20.98%	39.58%
D&A For EBITDA	1,836	1,735	1,468
EBIT	2,788	1,379	5,640
EBIT Margin	15.78%	9.29%	31.41%
Effective Tax Rate	16.27%	12.26%	12.95%
Advertising Expenses	-	123.34	312.82

Source: S&P Capital IQ. Standard template. Financial Sources.